Optimizing the aldosterone-to-renin ratio cut-off for screening primary aldosteronism based on cardiovascular risk: a collaborative study

Chunxue He,Ruolin Li,Jun Yang,Hang Shen,Yue Wang,Xiangjun Chen,Wenjin Luo,Qinglian Zeng,Linqiang Ma,Ying Song,Qingfeng Cheng,Zhihong Wang,Fei-Fei Wu,Qifu Li,Shumin Yang,Jinbo Hu
DOI: https://doi.org/10.1080/10641963.2023.2301571
2024-01-28
Clinical and Experimental Hypertension
Abstract:Objectives Aldosterone-to-renin ratio (ARR) based screening is the first step in the diagnosis of primary aldosteronism (PA). However, the guideline-recommended ARR cutoff covers a wide range, from the equivalent of 1.3 to 4.9 ng·dl −1 /mIU∙l −1 . We aimed to optimize the ARR cutoff for PA screening based on the risk of cardiovascular diseases (CVD).
pharmacology & pharmacy,peripheral vascular disease
What problem does this paper attempt to address?